MOLECULAR EPIDEMIOLOGY AND THE GENETICS OF ENVIRONMENTAL CANCER

被引:167
作者
SHIELDS, PG [1 ]
HARRIS, CC [1 ]
机构
[1] NCI,HUMAN CARCINOGENESIS LAB,BLDG 37,ROOM 2C01,BETHESDA,MD 20892
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1991年 / 266卷 / 05期
关键词
D O I
10.1001/jama.266.5.681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Environmental, occupational, and recreational exposures to carcinogens contribute to cancer risk in humans. Cancer formation is a multistage process involving tumor initiation, promotion, conversion, and progression. Carcinogens can affect any of these stages through genetic and epigenetic mechanisms. The association of a suspected carcinogenic exposure and cancer risk can be studied in populations with classic epidemiologic techniques. However, these techniques are not applicable to the assessment of risk in individuals. Molecular epidemiology, in contrast, is a field that integrates molecular biology, in vitro and in vivo laboratory models, biochemistry, and epidemiology to infer individual cancer risk. Carcinogen-macromolecular adduct levels, and somatic cell mutations can be measured to determine the biologically effective dose of a carcinogen. Molecular epidemiology also explores host cancer susceptibilities, such as carcinogen metabolic activation, DNA repair, endogenous mutation rates, and inheritance of mutated tumor suppressor genes. Substantial interindividual variation for each of these biologic end points has been shown and, therefore, highlights the need for assessing cancer risk on an individual basis. Given the pace of the last decade, it is feasible that the next 10 years will allow molecular epidemiologists to develop a cancer-risk profile for an individual that includes assessment of a number of factors. This will help focus preventive strategies and strengthen quantitative risk assessments.
引用
收藏
页码:681 / 687
页数:7
相关论文
共 96 条
  • [2] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER
    AYESH, R
    IDLE, JR
    RITCHIE, JC
    CROTHERS, MJ
    HETZEL, MR
    [J]. NATURE, 1984, 312 (5990) : 169 - 170
  • [3] RAS GENES
    BARBACID, M
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 : 779 - 827
  • [4] POSSIBLE PROGNOSTIC VALUE OF PULMONARY AH-LOCUS-LINKED ENZYMES IN PATIENTS WITH TOBACCO-RELATED LUNG-CANCER
    BARTSCH, H
    HIETANEN, E
    PETRUZZELLI, S
    GIUNTINI, C
    SARACCI, R
    MUSSI, A
    ANGELETTI, CA
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (02) : 185 - 188
  • [5] BELAND FA, 1989, PATHOBIOLOGY NEOPLAS, P57
  • [6] MOLECULAR THEMES IN ONCOGENESIS
    BISHOP, JM
    [J]. CELL, 1991, 64 (02) : 235 - 248
  • [7] BOUCK N, 1990, CANCER CELL-MON REV, V2, P179
  • [8] SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA
    BRESSAC, B
    KEW, M
    WANDS, J
    OZTURK, M
    [J]. NATURE, 1991, 350 (6317) : 429 - 431
  • [9] CARCINOGEN-INDUCED MUTATIONS IN THE MOUSE C-HA-RAS GENE PROVIDE EVIDENCE OF MULTIPLE PATHWAYS FOR TUMOR PROGRESSION
    BROWN, K
    BUCHMANN, A
    BALMAIN, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) : 538 - 542
  • [10] HEMOGLOBIN ADDUCTS OF AROMATIC-AMINES - ASSOCIATIONS WITH SMOKING STATUS AND TYPE OF TOBACCO
    BRYANT, MS
    VINEIS, P
    SKIPPER, PL
    TANNENBAUM, SR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (24) : 9788 - 9791